(4 Ue } KY
MAY 27 2008 SECTION 9
510(k) SUMMARY 9 22447
This 510(k) summary of safety and effectiveness for Norseld Dual Yellow D10B laser is
submitted in accordance with the requirements of SMDA 1990 and follows Office of Device
Evaluation guidance concerning the organization and content of a 510(k) summary.
Applicant: Norseld Pty., Ltd.
Address: 9 Claxton St
Adelaide
South Australia 5000
Manufacturer: Norseld Pty, Ltd.
9 Claxton St
Adelaide
South Australia 5000
Contact Person: Mr. Peter Davis
Managing Director
Telephone Number: 011-8-8231 9000
Fax Number: 011-8-8231 9009
Preparation Date: January 2004
(of the Summary)
Device Name: Dual Yellow Laser, Dual Yellow D10B Laser
Common Name: Laser surgical device
Classification: — Laser surgical device
Class II medical device
. 21 CFR 878.4810
Product Code: GEX
Panel: 79
Predicate devices: ICN (and SLS BIOPHILE) NLite Laser Systems (K000811, K020729,
K013461, K014130); Candela Vbeam (K021180), and Norseld Dual Yellow
Laser (K023899); Asclepion-Meditec YelloStar(K013940); COSMOS
COMPACT KTP (K983020); Dio-LighV/DioLite (K981447, K980201,
K964074); Laserscope Lyra (K990903); and Viridis Laser (K001784).
O17?

AG
CO3U347 Dae v oX 3
Device description: The Norseld Dual Yellow D10B Laser is a copper bromide laser which
emits it energy at 511 and 578 nm. The device consists of an cabinet, fiber
optic delivery system, and a user/software interface.
Indications: The Dual Yellow laser is indicated for the treatment of benign pigmented
and cutaneous vascular lesions.
The Dual Yellow laser, operating at 578 nm, is indicated in dermatology,
plastic surgery, and general surgery for treatment of benign cutaneous
vascular lesions including but not limited to:
Treatment of wrinkles,
Periocular wrinkles,
Periorbital wrinkles.
Facial and leg telangiectasia,
Rosacea,
Cherry angiomas,
Port wine stains,
Hemangiomas and venous lakes,
Angioma,
Spider angioma, and
Poikiloderma of Civatte,
Inflammatory Acne Vulgaris,
Verrucae/Warts,
Scars,
Striea, and
Psoriasis.
Podiatry - for benign cutaneous lesions and warts.
The Dual Yellow lase, operating at 511 nm, is indicated in dermatology,
plastic surgery, and general surgery for treatment of benign cutaneous
pigmented lesions including but not limited to:
Lentigines,
Solar keratoses,
Adenoma serabaceum,
Skin tabs,
Trichoepitheliomas (benign lesions similar to skin tags)
Naevi,
Keratoses,
Syringomas
Seborrhocic keratoses
Verrucae vulgaris, and
Warts.
518

a 47
oO ,
a

Performance Data: Supporting literature and articles were provided in support of the

indications for use of the 511 nm wavelength.
The results of a published clinical study were submitted in support of the
indication for the treatment of inflammatory acne vulgaris using the 578
nm wavelength. Indications for the 578 nm wavelength were based on
equivalency to cited legally marketed products.

CONCLUSION: Based on the information in the notification Norseld Pty., Ltd. believes
that Dual Yellow D10B Laser is substantially equivalent to the cited
legally marketed predicates for the indications listed above..

/ rev. 2/2004
O19

mere
f & DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
ea
Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20860
MAY 27 2004
Norseld Pty., Ltd.
c/o Mr. Roger Barnes /
342 Sunset Bay Road
Hot Springs, Arkansas 71913
Re: K032397
Trade/Device Name: Norseld Pty., Ltd.
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: February 24, 2004
Received: March 1, 2004
Dear Mr. Barnes:
We have revicwed your Scction 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the ederal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CIR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Roger Barnes
This letter will allow you to begin marketing your device as described in your Section 5 10¢k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
“"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.himl

Sincerely yours,

P* Celia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

SECTION 7
page 1 E
INDICATIONS FOR USE STATEMENT
510(k) Number (if known): _K032397
Device Name: Norseld Pty., Ltd. Dual Yellow (Dual Yellow D10B Laser)
Indications for Use Statement:

The Dual Yellow laser, operating at 578 nm, is indicated in dermatology, plastic surgery,

and general surgery for treatment of benign cutaneous vascular lesions including but not

limited to:
Treatment of wrinkles,
Periocular wrinkles,
Periorbital wrinkles.
Facial and leg telangiectasia,
Rosacea,
Cherry angiomas,
Port wine stains,
Hemangiomas and venous lakes,
Angioma,
Spider angioma, and
Poikiloderma of Civatte,
Inflammatory Acne Vulgaris,
Verrucae/Warts,
Scars,
Striea, and :
Psoriasis.
Podiatry - for benign cutaneous lesions and warts.

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
ee
Concurrence of CDRH, Office of Device Evaluation
Prescription Use X_ “tly, To tle Counter Use ___
(Per 21 CFR 801.109) —— n

(Division Sign-Off)

Division of General, Restorative,

and Neurological Devices As
2344

510(k) Number___KOS231

2 of ’
p Age
INDICATIONS FOR USE (continued):
The Dual Yellow lase, operating at 511 nm, is indicated in dermatology, plastic surgery,
and general surgery for treatment of benign cutaneous pigmented lesions including but
not limited to: .
Lentigines,
Solar keratoses,
Adenoma serabaceum,
Skin tabs,
Trichoepitheliomas (benign lesions similar to skin tags)
Naevi,
Keratoses,
Syringomas ‘
Seborrhoeic keratoses
Verrucac vulgaris, and
Warts.
th A Alen
rev. 2/2004 f (Division Sign-O )
Division of Genevai, Restorative,
and Neurologics. wevices
510(k) Namber__KO39-347 016

